Privigen (human normal immunoglobulin): Reviews and patient testimonials
Back to the list of medications
Medication indications
Privigen 100mg/ml solution for infusion
Replacement therapy in adults, and children and adolescents (0-18 years) in:
• Primary immunodeficiency (PID) syndromes with impaired antibody production.
• Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
• Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
• Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
• Congenital AIDS with recurrent bacterial infections.
Immunomodulation in adults, and children and adolescents (0-18 years) in:
• Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
• Guillain-Barré syndrome.
• Kawasaki disease.
• Chronic inflammatory demyelinating polyneuropathy (CIDP). Only limited experience is available of use of intravenous immunoglobulins in children with CIDP.
Route of administration: Injectable
Molecule: human normal immunoglobulin
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.